Intranasal Glucagon for Treatment of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes: A Randomized Crossover Noninferiority Study

OBJECTIVE: Treatment of severe hypoglycemia with loss of consciousness or seizure outside of the hospital setting is presently limited to intramuscular glucagon requiring reconstitution immediately prior to injection, a process prone to error or omission. A needle-free intranasal glucagon preparatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rickels, Michael R., Ruedy, Katrina J., Foster, Nicole C., Piché, Claude A., Dulude, Hélène, Sherr, Jennifer L., Tamborlane, William V., Bethin, Kathleen E., DiMeglio, Linda A., Wadwa, R. Paul, Ahmann, Andrew J., Haller, Michael J., Nathan, Brandon M., Marcovina, Santica M., Rampakakis, Emmanouil, Meng, Linyan, Beck, Roy W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2016
Materias:
Epidemiology/Health Services Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722945/
https://www.ncbi.nlm.nih.gov/pubmed/26681725
http://dx.doi.org/10.2337/dc15-1498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722945/
https://www.ncbi.nlm.nih.gov/pubmed/26681725
http://dx.doi.org/10.2337/dc15-1498

Ejemplares similares